Table 3.
Principles for decision-making
| Overarching principles |
| Clinically driven |
| • Patient participation and autonomy will be fostered. |
| • Genome data will be analysed according to clinical indication. |
| Collaborative |
| • Genomic data will be shared for clinical and research use according to existing regulations for health records and ethical standards. |
| • Common systems and standards apply where they will facilitate access to and (re-) use of genomic information by multiple partners throughout the patient’s lifetime and across the research-translation continuum. |
| • Each member remains responsible for business decisions about the services it provides and the resourcing and quality assurance of those services. |
| • Each hospital remains responsible for procurement of genomic testing for their patients, subject to the provider meeting the shared standards. |
| Sustainable |
| • Decisions during development will be ‘user-focussed’—where those users are variously patients, clinicians, researchers and diagnostic laboratories—and evidence-based. |
| • Systems will be designed for optimal (financial) sustainability, scalability, incorporation of future -omics advances and future inclusion of organisations outside the founding members. |